Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services
What You Should Know:
– Regeneron Pharmaceuticals, Inc. announced it has been named the successful bidder in the bankruptcy auction for substantially all of the assets of 23andMe Holding Co.
– Regeneron plans to acquire 23andMe’s…
Continue Reading